286 related articles for article (PubMed ID: 24170197)
1. Association between recent use of fluoroquinolones and rhegmatogenous retinal detachment: a population-based cohort study.
Kuo SC; Chen YT; Lee YT; Fan NW; Chen SJ; Li SY; Liu CJ; Chen TL; Chen TJ; Fung CP
Clin Infect Dis; 2014 Jan; 58(2):197-203. PubMed ID: 24170197
[TBL] [Abstract][Full Text] [Related]
2. Administration of oral fluoroquinolone and the risk of rhegmatogenous retinal detachment: A nationwide population-based study in Korea.
Choi SY; Lim HA; Yim HW; Park YH
PLoS One; 2018; 13(4):e0195563. PubMed ID: 29649310
[TBL] [Abstract][Full Text] [Related]
3. An investigation of the potential association between retinal detachment and oral fluoroquinolones: a self-controlled case series study.
Chui CS; Man KK; Cheng CL; Chan EW; Lau WC; Cheng VC; Wong DS; Yang Kao YH; Wong IC
J Antimicrob Chemother; 2014 Sep; 69(9):2563-7. PubMed ID: 24833754
[TBL] [Abstract][Full Text] [Related]
4. Signal Detection Between Fluoroquinolone Use and the Risk of Rhegmatogenous Retinal Detachment: Sequence Symmetry Analysis Using Nationwide South Korean Healthcare Database Between 2004 and 2015.
Baek YH; Park SJ; Jeong S; Oh IS; Jeong HE; Park KH; Shin JY
Clin Drug Investig; 2018 Dec; 38(12):1179-1188. PubMed ID: 30276555
[TBL] [Abstract][Full Text] [Related]
5. Association between oral fluoroquinolone use and retinal detachment.
Pasternak B; Svanström H; Melbye M; Hviid A
JAMA; 2013 Nov; 310(20):2184-90. PubMed ID: 24281462
[TBL] [Abstract][Full Text] [Related]
6. Association Between Oral Fluoroquinolone Use and Retinal Detachment.
Raguideau F; Lemaitre M; Dray-Spira R; Zureik M
JAMA Ophthalmol; 2016 Apr; 134(4):415-21. PubMed ID: 26967005
[TBL] [Abstract][Full Text] [Related]
7. RISK OF RHEGMATOGENOUS RETINAL DETACHMENT WITH CENTRAL SEROUS CHORIORETINOPATHY.
Chang YS; Chang C; Weng SF; Wang JJ; Jan RL
Retina; 2016 Aug; 36(8):1446-53. PubMed ID: 26716956
[TBL] [Abstract][Full Text] [Related]
8. The risk profile of rhegmatogenous retinal detachment before and after using a fluoroquinolone: a 12 year nationwide self-controlled case series study.
Shin JY; Jeong S; Jeon HL; Byun S; Park KH; Jeong HE; Park SJ
J Antimicrob Chemother; 2018 Dec; 73(12):3442-3453. PubMed ID: 30165476
[TBL] [Abstract][Full Text] [Related]
9. Risk of severe dysglycemia among diabetic patients receiving levofloxacin, ciprofloxacin, or moxifloxacin in Taiwan.
Chou HW; Wang JL; Chang CH; Lee JJ; Shau WY; Lai MS
Clin Infect Dis; 2013 Oct; 57(7):971-80. PubMed ID: 23948133
[TBL] [Abstract][Full Text] [Related]
10. Risk of retinal tear or detachment with oral fluoroquinolone use: a cohort study.
Eftekhari K; Ghodasra DH; Haynes K; Chen J; Kempen JH; VanderBeek BL
Pharmacoepidemiol Drug Saf; 2014 Jul; 23(7):745-52. PubMed ID: 24757075
[TBL] [Abstract][Full Text] [Related]
11. Incidence rates of retinal detachment in 2 cohorts of patients treated with oral fluoroquinolones or amoxicillin.
Farioli A; Kriebel D
Clin Infect Dis; 2014 May; 58(10):1489-90. PubMed ID: 24610425
[No Abstract] [Full Text] [Related]
12. Oral fluoroquinolones and the risk of retinal detachment.
Etminan M; Forooghian F; Brophy JM; Bird ST; Maberley D
JAMA; 2012 Apr; 307(13):1414-9. PubMed ID: 22474205
[TBL] [Abstract][Full Text] [Related]
13. Oral fluoroquinolones and the incidence of rhegmatogenous retinal detachment and symptomatic retinal breaks: a population-based study.
Kapoor KG; Hodge DO; St Sauver JL; Barkmeier AJ
Ophthalmology; 2014 Jun; 121(6):1269-73. PubMed ID: 24480710
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and clinical characteristics of rhegmatogenous retinal detachment in Taiwan.
Chen SN; Lian IeB; Wei YJ
Br J Ophthalmol; 2016 Sep; 100(9):1216-20. PubMed ID: 26659711
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of primary rhegmatogenous retinal detachment in Taiwan.
Chou SC; Yang CH; Lee CH; Yang CM; Ho TC; Huang JS; Lin CP; Chen MS; Shih YF
Eye (Lond); 2007 Aug; 21(8):1056-61. PubMed ID: 16691255
[TBL] [Abstract][Full Text] [Related]
16. Rhegmatogenous retinal detachment and uveitis.
Kerkhoff FT; Lamberts QJ; van den Biesen PR; Rothova A
Ophthalmology; 2003 Feb; 110(2):427-31. PubMed ID: 12578792
[TBL] [Abstract][Full Text] [Related]
17. Risks of cardiac arrhythmia and mortality among patients using new-generation macrolides, fluoroquinolones, and β-lactam/β-lactamase inhibitors: a Taiwanese nationwide study.
Chou HW; Wang JL; Chang CH; Lai CL; Lai MS; Chan KA
Clin Infect Dis; 2015 Feb; 60(4):566-77. PubMed ID: 25409476
[TBL] [Abstract][Full Text] [Related]
18. Association between oral fluoroquinolone use and the development of retinal detachment: a systematic review and meta-analysis of observational studies.
Chui CS; Wong IC; Wong LY; Chan EW
J Antimicrob Chemother; 2015 Apr; 70(4):971-8. PubMed ID: 25525200
[TBL] [Abstract][Full Text] [Related]
19. Fluoroquinolones and collagen associated severe adverse events: a longitudinal cohort study.
Daneman N; Lu H; Redelmeier DA
BMJ Open; 2015 Nov; 5(11):e010077. PubMed ID: 26582407
[TBL] [Abstract][Full Text] [Related]
20. Analyses of fluoroquinolones and Clostridium difficile-associated diarrhoea in tuberculosis patients.
Chang KC; Leung CC; Yew WW; Lam FM; Ho PL; Chau CH; Cheng VC; Yuen KY
Int J Tuberc Lung Dis; 2009 Mar; 13(3):341-6. PubMed ID: 19275794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
